Social Media Press Releases
RSSShowing Press Releases in Category: Company News
11/28/2011
ASTRAZENECA COMMITS AN ADDITIONAL $100 MILLION TO VENTURE CAPITAL ARM MEDIMMUNE VENTURES
» read more11/08/2011
MEDIMMUNE MANUFACTURING FACILITY RECOGNIZED AS 2011 FACILITY OF THE YEAR IN PHARMACEUTICAL ENGINEERING
» read more10/21/2011
MEDIMMUNE TO PRESENT PHASE 3 PEDIATRIC CLINICAL DATA FOR QUADRIVALENT INFLUENZA AT 49TH ANNUAL IDSA MEETING
» read more10/13/2011
“WHEN WILL YOU PICK?” CAMPAIGN ENCOURAGES FAMILIES TO MAKE FLU VACCINATION A PRIORITY THIS FALL
» read more8/09/2011
MEDIMMUNE SCIENTISTS NAMED AMONG “100 MOST INSPIRING PEOPLE IN LIFE SCIENCES INDUSTRY”
» read more7/18/2011
MEDIMMUNE SUBMITS SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION FOR QUADRIVALENT SEASONAL NASAL SPRAY INFLUENZA VACCINE
» read more5/13/2011
MEDIMMUNE TO PRESENT EIGHT ABSTRACTS ON PROJECTS REGARDING THORACIC AND RESPIRATORY ISSUES AT THE ANNUAL AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE
» read more5/02/2011
MEDIMMUNE TO PRESENT ELEVEN ABSTRACTS ON INFLUENZA AND RESPIRATORY SYNCYTIAL VIRUS AT THE ANNUAL PEDIATRIC ACADEMIC SOCIETIES MEETING
» read more4/04/2011
MEDIMMUNE, INSERM AND INSERM TRANSFERT ANNOUNCE STRATEGIC COLLABORATION TO FUND AND CONDUCT MEDICAL SCIENCE RESEARCH
» read more3/29/2011
MEDIMMUNE TO PRESENT 11 ABSTRACTS ON INFLUENZA AT 45th ANNUAL NATIONAL IMMUNIZATION CONFERENCE
» read more2/01/2011
EUROPEAN COMMISSION APPROVES NASAL SPRAY VACCINE FLUENZ FOR THE PREVENTION OF SEASONAL INFLUENZA IN CHILDREN
» read more1/20/2011
